Skip to content

Correction of umbilical hernia with anterior muscle tissue compared to posterior muscular tissue

Umbilical herniaplasty onlay versus sublay

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-4n4c4z
Enrollment
Unknown
Registered
2018-03-27
Start date
2017-10-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

umbilical hernia

Interventions

Patients with umbilical hernia will be randomized to perform onlay (n 73) or sublay (n 73) hernioplasty. All patients will be submitted to a supra or infraumbilical incision, hernia sac and reduction
Procedure/surgery

Sponsors

Hospital Presidente Vargas
Lead Sponsor
Hospital Presidente Vargas
Collaborator

Eligibility

Sex/Gender
Female
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Female patients; 18 years of age or older; presenting with primary umbilical hernia.

Exclusion criteria

Exclusion criteria: Patients with relapsed umbilical hernia; need for another concomitant surgical procedure.

Design outcomes

Primary

MeasureTime frame
The primary outcome will be the occurrence of surgical site events (Surgical-Site Occurrence - SSO) described by Ventral Hernia Working Group (VHWG): infection, suture dehiscence, seroma, or enterocutaneous fistula. The surgical wound infection will be defined as that occurring within the first 30 days of surgery, involving only the skin and the subcutaneous tissue, presenting at least one of the following signs and symptoms: pain, increased sensitivity, erythema, local heat and purulent secretion. The dehiscence of the suture will be characterized by the removal of the edges of the surgical wound in the first 30 postoperative days. The seroma will be defined as accumulation of non-purulent secretion under the operative wound, with serosanguinolent appearance. If it is found, it will be punctured by aseptic method, and the amount of liquid withdrawn will be recorded. The enterocutaneous fistula will be recorded in the case of enteric contents through the surgical wound, occurring at any time during the period of follow-up of the study.

Secondary

MeasureTime frame
Pain will be assessed through the Visual Analogue Scale, which ranges from 0 to 10, with 10 being the most severe pain experienced by the patient and 0 being painless. This variable will be recorded in all postoperative consultations. Chronic pain will be one that persists after three months of the surgical procedure. Also will be recorded the return time to daily activities. ;Secondary outcome 2: Recurrence of umbilical hernia will be assessed by physical examination.

Countries

Brazil

Contacts

Public ContactLissandro Tarso

Hospital Presidente Vargas

lissandrotarso@hotmail.com+5551999774962

Outcome results

None listed

Source: REBEC (via WHO ICTRP)